Efficacy And Safety Results From A Phase 2, Randomized, Double-Blind Trial Of Biib059, An Anti-Blood Dendritic Cell Antigen 2 Antibody, In SleRichard Furie,Ronald Van Vollenhoven,Kenneth Kalunian,Sandra Navarra,Juanita Romero-Diaz,Victoria Werth,Xiaobi Huang,Hua Carroll,Adam Meyers,Cristina Musselli,Catherine Barbey,Nathalie FranchimontARTHRITIS & RHEUMATOLOGY（2020）引用 11|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
